A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: A randomized, placebo-controlled study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 130, Issue 2, 2007, Pages 206-211

  Kurtay, G ^a   Ozmen, B ^a  

^a Faculty of Medicine   (Turkey)

Author keywords

Homocysteine; Hormone replacement therapy; Oral; Transdermal

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; FOLLITROPIN; HOMOCYSTEINE; LIPID; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

EID: 33846240495     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.05.021     Document Type: Article

References (39)

1. D'Angelo A., and Sehlub J. Homocysteine and thrombotic disease. Blood 90 1 (1997) 1-11
2. Jacobsen D.W. Homocysteine and vitamins in cardiovascular disease. Clin Chem 44 8B (1998) 1833-1843
3. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
4. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
5. Barrett-Connor E., and Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 19 (1998) 55-72
6. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
7. Ueland P.M., and Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 114 (1989) 473-501
8. Verhoef P., Meleady R., Daly L.E., Graham I.M., Robinson K., and Boers G.H. Homocysteine, vitamin status and risk of vascular disease: effects of gender and menopausal status. The European COMAC group. Eur Heart J 20 (1999) 1234-1244
9. Hak A.E., Polderman K.H., Westendrop I.C.D., Jakobs C., Hofman A., and Witteman J.C.M. Increased plasma homocysteine after menopause. Atherosclerosis 149 (2000) 163-168
10. Wouter M.G.A., Moorrees M.T., van der Mooren M.L., et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 25 (1995) 801-805
11. De Bree A., Verschuren V.M., Blom H.J., de Graaf-Hess A., Trijbels F.J., and Kromhout D. The homocysteine distribution: (mis)judging the burden. J Clin Epidemiol 54 (2001) 462-469
12. Kang S.S., Wong P.W., Zhou J.M., and Cook H.Y. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women. Metabolism 35 (1986) 889-891
13. Andersson A., Hultberg B., Brattstrom L., and Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 30 (1992) 377-379
14. Van der Mooren M.J., Mijatovic V., van Baal W.M., and Stehouwer C.D.A. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease. Maturitas 30 (1998) 27-36
15. Man R.Y., Ting L.K., Fan S., et al. Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women. Mol Cell Biochem 225 (2001) 129-134
16. Mijatovic V., Kenemans P., Netelenbos J.C., et al. Postmenopausal oral 17 β-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil Steril 69 (1998) 876-882
17. Mijatovic V., Kenemans P., Jakobs C., van Baal W.M., Peters-Muller E.R., and van der Mooren M.J. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 91 (1998) 432-436 12
18. Van Baal W.M., Smolders R.G.V., Van der Mooren M.J., Teerlink T., and Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 93 (1999) 486-493
19. Van der Mooren M.J., Wouters M.G., Blom H.J., Schellekens L.A., Eskes T.K., and Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 24 (1994) 733-736
20. Walsh B.W., Paul S., Wild R.A., et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 8 (2000) 214-218
21. Evio S., Tiitinen A., Turpeinen U., and Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril 74 (2000) 1080-1083
22. Farag N.H., Barshop B.A., and Mills P.J. Effects of estrogen and psychological stress on plasma homocysteine levels. Fertil Steril 79 (2003) 256-260
23. Noto R., Neri S., Molino G., et al. Hyperhomocysteinemia in menopausal hypertension: an added risk factor and a dangerous association for organ damage. Eur Rev Med Pharmacol Sci 6 4 (2002) 81-87
24. Barnabei V.M., Phillips T.M., and Hsia J. Plasma homocysteine in women taking hormone replacement therapy: the postmenopausal estrogen/progestin interventions (PEPI) trial. J Womens Health Gend Based Med 8 (1999) 1167-1172
25. Blom H.J., Boers G.H., van den Elzen J.P., van Roessel J.J., Trijbels J.M., and Tangerman A. Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease. Eur J Clin Invest 18 (1988) 633-638
26. Smolders R.G., de Meer K., Kenemans P., Teerlink T., Jakobs C., and van der Mooren MJ. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 117 1 (2004) 55-59
27. Smolders R.G., de Meer K., Kenemans P., Jakobs C., Kulik W., and van der Mooren M.J. Oral estradiol decreases plasma homocysteine, vitamin B6, and albumin in postmenopausal women but does not change the whole-body homocysteine remethylation and transmethylation flux. J Clin Endocrinol Metab 90 4 (2005) 2218-2224
28. Somekawa Y., Kobayashi K., Somura T., Aso T., and Hamaguchi H. Effects of hormone replacement therapy and methylenetetrahydrofolate reductase polymorphism on plasma folate and homocysteine levels in postmenopausal Japanese women. Fertil Steril 77 (2002) 481-486
29. De Leo V., la Marca A., Morgante G., Musacchio M.C., Luisi S., and Petraglia F. Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment. Treat Endocrinol 3 6 (2004) 393-400
30. Bednarek-Tupikowska G., and Tupikowski K. Homocysteine - an underestimated atheromatosis risk factor. Do sex hormones influence homocysteine concentrations?. Postepy Hig Med Dosw (Online) 58 (2004) 381-389
31. Lacut K., Oger E., Abalain J.H., Moineau M.P., Mottier D., and SARAH Investigators. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial. Atherosclerosis 174 1 (2004) 173-180
32. Bruschi F., Dal Pino D., Fiore V., et al. Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial. Maturitas 48 1 (2004) 33-38
33. Chiantera V., Sarti C.D., Fornaro F., et al. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Menopause 10 4 (2003) 286-291
34. Yildirir A., Aybar F., Tokgozoglu L., et al. Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. Gynecol Obstet Invest 53 1 (2002) 54-58
35. Smolders R.G., van der Mooren M.J., Teerlink T., et al. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertil Steril 79 2 (2003) 261-267
36. Madsen J.S., Kristensen S.R., Klitgaard N.A., et al. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. Am J Obstet Gynecol 187 1 (2002) 33-39
37. Ventura P., Cagnacci A., Malmusi S., et al. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause 8 4 (2001) 252-258
38. Os I., Os A., Sandset P.M., et al. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine. Cardiology 98 1-2 (2002) 6-12
39. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 380 (1998) 605-613